Wave Life Sciences Ltd.
WVE
Get informed when a big investor buys or sells
+ FollowMarket Cap$857.16M
Close$
$0.58
85.2% downside
Current Fair Value
85.2% downsideOvervalued by 85.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $857.16 Million |
|---|---|
| Enterprise Value | $541.44 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.21 |
| Beta | -1.3 |
| Outstanding Shares | 202,098,901 |
Return
| Return on Equity | -44.64% |
|---|---|
| Return on Assets | -35.85% |
| Return on Invested Capital | -42.92% |
Valuation & Multiples
| P/E Ratio | -3.99 |
|---|---|
| PEG | -10.66 |
| Price to Sales | - |
| Price to Book Ratio | 1.98 |
| Enterprise Value to Revenue | 8.28 |
| Enterprise Value to EBIT | -2.56 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.12 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 30, 2026
EPS Estimate
$-0.30
Average shareholder expectationRevenue Estimate
$7.45 M
Average shareholder expectationNext Earnings Call
Expected Date
November 9, 2026
EPS Estimate
$-0.33
Average shareholder expectationRevenue Estimate
$5.03 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.4669▲ 15.22% |
|---|---|
| Total Calls | 426,000▼ 88.37% |
| Total Puts | 198,900▼ 82.74% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 90.75%▲ 4.45% |
|---|---|
| Total Invested | $1.07B▼ 14.86% |
| Investors Holding | 250▼ 5.00% |
ESG Score
No data
About Wave Life Sciences Ltd.
CEO: Paul Bolno